Clinical Trial Update: Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) [Phase 4]

View source ↗

Summary

Phase 4 trial updates efficacy and safety of belimumab in Black patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Human Genome Sciences Inc., a GSK Company | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED | Results posted: 2019-07-05